Lee Ainslie Maverick Capital
Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EA
Electronic Arts
EA
|
+$96.5M |
| 2 |
GFL Environmental
GFL
|
+$92.9M |
| 3 |
QuidelOrtho
QDEL
|
+$79.1M |
| 4 |
Astera Labs
ALAB
|
+$73.9M |
| 5 |
Natera
NTRA
|
+$60.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$307M |
| 2 |
Constellation Brands
STZ
|
+$86.1M |
| 3 |
Domino's
DPZ
|
+$76.7M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$73.9M |
| 5 |
Meta Platforms (Facebook)
META
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 32.34% |
| 2 | Technology | 17.7% |
| 3 | Healthcare | 16.82% |
| 4 | Financials | 10.98% |
| 5 | Real Estate | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Republic Services
RSG
$67.6B
| – | – |
-1,429
| Closed | -$236K |
|
527
Southern Copper
SCCO
$182B
| – | – |
-5,482
| Closed | -$432K |
|
528
SEI Investments
SEIC
$13.1B
| – | – |
-5,963
| Closed | -$379K |
|
529
Shake Shack
SHAK
$3.06B
| – | – |
-6,209
| Closed | -$460K |
|
530
Signet Jewelers
SIG
$3.16B
| – | – |
-28,690
| Closed | -$3.08M |
|
531
SiriusXM
SIRI
$9.67B
| – | – |
-7,109
| Closed | -$389K |
|
532
Silgan Holdings
SLGN
$4.48B
| – | – |
-6,447
| Closed | -$292K |
|
533
Synopsys
SNPS
$76.2B
| – | – |
-1,069
| Closed | -$550K |
|
534
Southern Company
SO
$102B
| – | – |
-3,464
| Closed | -$243K |
|
535
SS&C Technologies
SSNC
$19.5B
| – | – |
-6,481
| Closed | -$396K |
|
536
Sensata Technologies
ST
$6.23B
| – | – |
-16,405
| Closed | -$616K |
|
537
Synchrony
SYF
$25.9B
| – | – |
-6,788
| Closed | -$259K |
|
538
CALL
Symbotic
SYM
$5.43B
| – | – |
-320,200
| Closed | -$16.4M |
|
539
AT&T
T
$173B
| – | – |
-13,674
| Closed | -$229K |
|
540
Molson Coors Class B
TAP
$8.01B
| – | – |
-25,399
| Closed | -$1.55M |
|
541
Teradyne
TER
$58.7B
| – | – |
-4,337
| Closed | -$471K |
|
542
Tenet Healthcare
THC
$22.6B
| – | – |
-10,153
| Closed | -$767K |
|
|
THS
543
DELISTED
Treehouse Foods
THS
| – | – |
-26,900
| Closed | -$1.12M |
|
544
Toll Brothers
TOL
$13.7B
| – | – |
-4,913
| Closed | -$505K |
|
545
TC Energy
TRP
$64.6B
| – | – |
-6,312
| Closed | -$247K |
|
546
Tractor Supply
TSCO
$18.2B
| – | – |
-16,285
| Closed | -$700K |
|
547
Texas Roadhouse
TXRH
$13.4B
| – | – |
-23,587
| Closed | -$2.88M |
|
548
Ulta Beauty
ULTA
$22.4B
| – | – |
-9,483
| Closed | -$4.65M |
|
549
United Natural Foods
UNFI
$2.91B
| – | – |
-16,825
| Closed | -$273K |
|
550
Unum
UNM
$13.9B
| – | – |
-6,844
| Closed | -$309K |
|
Similar funds
Lee Ainslie's Q1 2024 Portfolio in Review
As of Q1 2024, Lee Ainslie held 573 positions worth $5.32B, up 6.9% from $4.98B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Lee Ainslie withdrew a net $210M in Q1 2024, closing 168 positions and reducing 68 holdings. Its most notable exit was Immunogen Inc, an estimated $73.9M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Lee Ainslie opened a new position in Electronic Arts worth $93.2M.
- Lee Ainslie's largest Q1 2024 buy was Electronic Arts: 702,830 shares worth $93.2M.
- Lee Ainslie added most to Starbucks in Q1 2024, an estimated $51.2M increase.
- Lee Ainslie's biggest Q1 2024 reduction was Coupang, cutting an estimated $307M.
- Lee Ainslie fully exited Immunogen Inc in Q1 2024, selling an estimated $73.9M.
- Lee Ainslie's ten largest holdings make up 45% of its $5.32B portfolio in Q1 2024.
- Lee Ainslie opened 225 new positions and closed 168 in Q1 2024.
- Lee Ainslie's portfolio value rose 6.9% quarter-over-quarter to $5.32B.
Based on Maverick Capital's 13F filing for Q1 2024, filed 15 May 2024.